In Brief: Intuitive Surgical
This article was originally published in The Gray Sheet
Executive Summary
Intuitive Surgical: U.S. clinical trials of a three-armed, tele-robotic instrumentation system for use in minimally invasive surgery will begin in the second quarter of 1998, Lonnie Smith, president and CEO, reports at a Dec. 2 session of the BancAmerica Robertson Stephens conference in New York City. The device, which would have broad applicability throughout the body including coronary bypass surgery, is intended to transform macromovements by the human hand into micromovements by remote controlled instruments inside the body...
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.